Market Overview

UPDATE: Morgan Stanley Reiterates on Genpact Limited as Risk-Reward is Favorable After Pullback

Related G
Earnings Scheduled For May 4, 2017
Keep an Eye on These 10 Stocks for February 10, 2017

In a report published Friday, Morgan Stanley analyst Vipin Khare reiterated an Overweight rating on Genpact Limited (NYSE: G), but lowered the price target from $21.00 to $18.00.

In the report, Morgan Stanley noted, “Large size and low penetration of the global BPO market are positives. Management sounded positive about its pipeline, but said that deal closures are taking longer than expected. The stock is down 11% since its Dec-13 quarter results, vs. +3% for the NYSE composite index. Based on our revised estimates of adjusted EPS, P/E is 15x for CY14 and 13x for CY15e, against a CY14e-16e earnings CAGR of 16%. We expect CY14 to be another year of investment – but once it starts yielding results, revenue growth could accelerate with improved margins. We now forecast muted revenue growth of ~5% in CY14e but expect growth rates to improve in 2015e.”

Genpact Limited closed on Thursday at $15.44.

Latest Ratings for G

Aug 2016Morgan StanleyDowngradesEqual-WeightUnderweight
Aug 2016BMO CapitalDowngradesOutperformMarket Perform
Aug 2016CitigroupMaintainsBuy

View More Analyst Ratings for G
View the Latest Analyst Ratings

Posted-In: Morgan Stanley Vipin KhareAnalyst Color Price Target Analyst Ratings


Related Articles (G)

View Comments and Join the Discussion!